세계의 식물 생명공학 시장(-2030년) : 제품 유형(작물 보호 및 영양 솔루션 제품, 바이오 종자 및 형질, 합성 바이올로지 대응 제품), 기술 유형, 작물 유형, 최종사용자, 지역별
Plant Biotechnology Market by Product Type (Crop Protection & Nutrition Solution Products, Biotech Seed & Traits, Synthetic Biology Enabled Products), Technology Type, Crop Type, End User, and Region - Global Forecast to 2030
상품코드:1698620
리서치사:MarketsandMarkets
발행일:2025년 04월
페이지 정보:영문 469 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계 식물 생명공학 시장 규모는 2025년 517억 3,000만 달러에서 예측 기간 동안 연평균 8.2% 성장하여 2030년에는 767억 9,000만 달러에 달할 것으로 예상됩니다.
식물 생명공학 시장은 지속 가능한 식량 생산, 기후 변화 대응 작물, 혁신적인 바이오 의약품 솔루션에 대한 세계 수요 증가에 힘입어 농업 및 생명과학 산업에서 중요한 분야로 부상하고 있습니다. 식물 생명공학은 작물의 형질을 강화하고, 수확량을 향상시키며, 새로운 식물 유래 제품을 개발하기 위해 유전공학, 분자 마커, 조직배양 기술을 활용하는 것을 말합니다. 이 시장은 CRISPR-Cas9 유전자 편집 기술의 발전, 농업 바이오 기술에 대한 투자 증가, 세계 인구 증가로 인한 식량 안보 문제를 해결해야 하는 절박한 필요성 등에 힘입어 지난 10년간 큰 성장을 이루었습니다.
조사 범위
조사 대상 연도
2025-2030년
기준 연도
2024년
예측 기간
2025-2030년
단위
금액(USD) 및 킬로톤
부문
기술 유형, 작물 유형, 최종 사용자, 제품 유형, 지역별
대상 지역
북미, 유럽, 아시아태평양, 남미 및 기타 지역
식물 생명공학 시장의 혁신 : 식물 생명공학 산업의 혁신은 종자 교체율 증가, 바이오 작물의 높은 채택률, 고부가가치 작물에 대한 수요 증가, 기후 변화에 대응하기 위한 식물 성장 조절제의 사용으로 인해 발생합니다. 바이오 기술의 혁신은 농업의 생산성과 품질을 향상시키고 궁극적으로 전 세계 농가의 소득을 향상시킬 수 있는 큰 잠재력을 가지고 있습니다. 또한, 식물 생명공학은 화학 농약에 대한 의존도를 줄임으로써 환경 문제도 해결하고 있습니다.
제품별로는 바이오 비료 부문이 예측 기간 동안 큰 시장 점유율을 차지할 것으로 예상됩니다.
바이오 비료는 식물의 성장을 가속하고 영양 공급을 강화하는 유용한 미생물을 함유하고 있습니다. 이러한 미생물 성분이 식물의 성장을 가속하고 수확을 유도하기 때문에 화학 비료의 대안이 될 수 있는 친환경 비료가 될 수 있습니다. 농부들은 특히 수경재배와 같은 토양을 사용하지 않는 재배 시스템이나 수직농법, 온실과 같은 제어환경농업(CEA) 시스템에서 바이오 비료를 채택하고 있습니다.
최종 사용자별로는 제약 및 바이오 의약품 부문이 예측 기간 동안 높은 속도로 성장할 것으로 예상됩니다:
제약 및 바이오 제약 산업은 식물 유래 백신, 생리활성 화합물, 유전자 변형 약용 식물 생산에 식물 생명공학을 활용하고 있습니다. 담배, 벼, 홍화 등의 식물은 치료용 단백질, 단클론 항체, 식용 백신을 생산하기 위해 조작되어 왔습니다. 식물 유래 의약품의 개발은 기존 바이오 의약품 방식에 비해 비용 효율성, 확장성, 오염 위험 감소로 인해 주목을 받고 있습니다. 식물 유래 의약품(PMP)을 개발하는 기업으로는 Medicago, Kentucky BioProcessing, Protalix BioTherapeutics 등이 있습니다.
지역별로는 유럽이 큰 비중을 차지할 전망입니다.
유럽은 최첨단 과학 기술 혁신, 엄격한 규제 프레임워크, 지속 가능한 농업과 환경 보호에 대한 깊은 헌신으로 특징지어지는 활기차고 복잡한 생태계를 갖춘 시장으로 두드러지고 있습니다.
세계의 식물 생명공학(Plant Biotechnology) 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 각종 영향요인 분석, 기술 및 특허 동향, 법 및 규제 환경, 사례 분석, 시장 규모 추이 및 예측, 각종 부문별/지역별/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 프리미엄 인사이트
제5장 시장 개요
거시경제 전망
상업용 종자 사용 증가
농지 손해와 손실
시장 역학
성장 촉진요인
성장 억제요인
기회
과제
AI/생성형 AI가 식물 생명공학 시장에 미치는 영향
제6장 업계 동향
고객의 비즈니스에 영향을 미치는 동향/파괴적 변화
밸류체인 분석
공급망 분석
기술 분석
무역 분석
가격 분석
생태계 분석
특허 분석
주요 컨퍼런스 및 이벤트
규제 상황
Porter의 Five Forces 분석
주요 이해관계자와 구입 기준
사례 연구 분석
투자 및 자금조달 시나리오
제7장 식물 생명공학 시장 : 기술별
유전자 공학
마커 지원 육종
유전자 편집
조직배양
합성 바이올로지
기타
제8장 식물 생명공학 시장 : 제품 유형별
작물 보호 및 영양 솔루션 제품
바이오 농약
바이오 비료
식물 성장 조절제
바이오 기술 종자 및 형질
내충성
제초제 내성
STACKED
합성 바이올로지 제품
제9장 식물 생명공학 시장 : 작물별
곡물
밀
옥수수
쌀
수수
보리
기타
지방종자 및 콩류
대두
카놀라
코튼
기타
과일 및 채소
석류 과일
감귤류
근채류
잎채소
기타
기타 작물
제10장 식물 생명공학 시장 : 최종사용자별
종자 기업
농업 자재 공급업체
식품 및 음료
바이오연료 및 생화학
제약 및 바이오의약품
정부 및 연구기관
제11장 식물 생명공학 시장 : 지역별
북미
미국
캐나다
멕시코
유럽
독일
프랑스
영국
이탈리아
스페인
기타
아시아태평양
중국
인도
일본
호주 및 뉴질랜드
기타
남미
브라질
아르헨티나
기타
기타 지역
중동
아프리카
제12장 경쟁 구도
개요
주요 시장 진출기업의 전략/강점
매출 분석
시장 점유율 분석
기업 평가와 재무 지표
브랜드/제품 비교
기업 평가 매트릭스 : 주요 기업
기업 평가 매트릭스 : 스타트업/중소기업
경쟁 시나리오
제13장 기업 개요
주요 기업
BASF SE
BAYER AG
CORTEVA AGRISCIENCE
SYNGENTA
KWS SAAT SE & CO. KGAA
UPL
FMC CORPORATION
SUMITOMO CHEMICAL CO., LTD.
NUFARM
PRO FARM GROUP
LIMAGRAIN
STK BIO-AG TECHNOLOGIES
CERTIS BIOLOGICALS
DLF SEEDS A/S
VESTARON CORPORATION
기타 기업
ROVENSA NEXT
IPL BIOLOGICALS
LALLEMAND INC.
RIZOBACTER ARGENTINA S.A.
ENZA ZADEN BEHEER B.V.
GENICA
KAY BEE BIO ORGANICS PVT. LTD.
VERDESIAN LIFE SCIENCES
BOTANOHEALTH
AXEB BIOTECH
제14장 인접 시장과 관련 시장
제15장 부록
LSH
영문 목차
영문목차
The global market for plant biotechnology is estimated to be valued at USD 51.73 billion in 2025 and is projected to reach USD 76.79 billion by 2030, at a CAGR of 8.2% during the forecast period. The plant biotechnology market has emerged as a critical sector within the broader agricultural and life sciences industries, driven by the increasing global demand for sustainable food production, climate-resilient crops, and innovative biopharmaceutical solutions. Plant biotechnology involves the use of genetic engineering, molecular markers, and tissue culture techniques to enhance crop traits, improve yield, and develop novel plant-based products. The market has witnessed significant growth over the past decade, fueled by advancements in CRISPR-Cas9 gene-editing technology, rising investments in agricultural biotechnology, and the pressing need to address food security challenges posed by a growing global population.
Scope of the Report
Years Considered for the Study
2025-2030
Base Year
2024
Forecast Period
2025-2030
Units Considered
Value (USD) and Volume (KT)
Segments
By Technology Type, Crop Type, End-User, Product Type, and Region
Regions covered
North America, Europe, Asia Pacific, South America, and RoW
Disruption in the plant biotechnology market: Market disruptions in the plant biotechnology industry are driven by rise in seed replacement rate, High adoption of biotech crops, Growing demand for high-value crops, Use of plant growth regulators to combat climatic changes. Innovations in biotechnology hold significant potential to boost agricultural productivity and quality, ultimately enhancing farmers' incomes globally. Moreover, plant biotechnology addresses environmental concerns by reducing reliance on chemical pesticides.
By product, biofertilizers subsegment in the biopesticides segment to hold significant market share during forecast period
Biofertilizers hold the useful microbes that stimulate plant growth in the way of enhanced nutrient supply. These microbial components start the growth of plants and provide yields, thereby making biofertilizers a viable, eco-friendly substitute for chemical fertilizers. Farmers are increasingly adopting biofertilizers, particularly in soil-less culture systems such as hydroponics and controlled environment agriculture (CEA) systems such as vertical farm and greenhouses.
Nanotechnology is revolutionizing biofertilizers using nanoparticles to enhance the efficiency of nutrient delivery and nutrient uptake in plants. The technology enhances the availability of nutrients, avoids nutrient leaching, and promotes sustainable nutrient management. Compared to synthetic fertilizers that render soils sterile after a few years, biofertilizers improve soil fertility through atmospheric nitrogen fixation and solubilization of sparingly soluble phosphate in soils. They help the plant defend itself against abiotic stress.
The biofertilizer market has shifted towards a scientific focus, and accordingly, research and development expenditures have increased. The key developments are the use of non-legume crops, biopolymers, use of mycorrhiza, and microbiome research. Danish researchers in 2022 created Bluubalance, a liquid biofertilizer that increases yield by 20% and reduces carbon waste by 98%. Biofertilizers are becoming an important part of sustainable agriculture, maintaining plant health with minimal harm to the environment
"The pharmaceutical and biopharma end-user segment is projected grow at signifiant rate during the forecast period."
The pharmaceutical and biopharma industries leverage plant biotechnology for the production of plant-derived vaccines, bioactive compounds, and genetically modified medicinal plants. Plants such as tobacco, rice, and safflower have been engineered to produce therapeutic proteins, monoclonal antibodies, and edible vaccines. The development of plant-based pharmaceuticals is gaining attention due to their cost-effectiveness, scalability, and reduced risk of contamination compared to traditional biopharma methods. Companies involved in plant-made pharmaceuticals (PMPs) include Medicago, Kentucky BioProcessing, and Protalix BioTherapeutics.
Biotech-enhanced plants like tobacco, rice, and maize are increasingly used as biofactories for producing pharmaceutical compounds due to their cost-effectiveness, scalability, and reduced risk of contamination compared to traditional cell culture systems. The development of plant-based biologics, including antibody therapies and enzyme replacements, has gained traction, offering new treatment avenues for diseases such as cancer, infectious diseases, and rare genetic disorders. Leading pharmaceutical and biopharma companies, along with biotech startups, are investing in plant-based expression platforms to accelerate drug production and enhance global healthcare accessibility. As demand for innovative biologics and cost-efficient biomanufacturing grows, plant biotechnology continues to play a crucial role in transforming the pharmaceutical industry.
Europe is expected to hold significant share in the plant biotechnology market.
Europe's plant biotechnology sector stands out as a vibrant and complex ecosystem, characterized by cutting-edge scientific innovation, rigorous regulatory frameworks, and a profound commitment to sustainable agriculture and environmental stewardship. This industry distinguishes itself from other global markets by uniquely blending advanced scientific research, ecological consciousness, and sophisticated regulatory oversight into a cohesive and forward-thinking approach.
The plant biotechnology landscape has undergone several transformations, driven by technological advances, environmental challenges, and a growing global need for sustainable agricultural innovations. European academic and research institutions have emerged as pivotal engines of this revolutionary domain. Renowned centers of excellence-including Germany's Max Planck Institute, the Netherlands' Wageningen University, and France's INRAE-are leading groundbreaking research in crop development, sustainable agricultural practices, positioning Europe at the cutting edge of agricultural science and sustainability.
In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the plant biotechnology market:
By Company Type: Tier 1 - 25%, Tier 2 - 45%, and Tier 3 - 30%
By Designation: Directors- 20%, Managers - 50%, Others- 30%
By Region: North America - 25%, Europe - 30%, Asia Pacific - 20%, South America - 15% and Rest of the World -10%
Prominent companies in the market BASF SE (Germany), Bayer AG (Germany), Corteva Agroscience (US), Syngenta AG ( Switzerland), FMC Corporation (US), UPL (India), Sumitomo Chemical Co. Ltd. (Japan), Nufarm (Australia), KWS SAAT SE & Co. KGAA (Germany), Pro Farm Group (US), Limagrain (France), STK Bio AG Technologies (Israel), Vestaron Corporation (US), Certis USA LLC (US), DLF Seeds (Denmark).
Other players include Rovensa Next (Spain), IPL Biologicals (India), Lallemand (Canada), Rizobacter Argentina S.A (Argentina), ENZA Zaden Beheer (Netherlands), Genica (Brazil), Kay Bee Bio Organics Pvt. Ltd. (India), Verdesian Life Sciences (US), BotanoHealth (Israel), Axeb Biotech (Spain) .
Research Coverage:
This research report categorizes the plant biotechnology market by technology type (genetic engineering, marker assissted breeding, genome editing, tissue culture, synthetic biology, other technologies), by crop type (cereals & grains, oilseeds & pulses, fruits & vegetables, other crop types), product (crop protection & nutrition solutions products, biotech seeds/ traits, synthetic biology enabled products), by end-user (seed companies, agricultural input suppliers, food & beverage industry, biofuel & biochemical companies, pharmaceutical & biopharma, government & research institutes), and region (North America, Europe, Asia Pacific, South America, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of plant biotechnology market. A detailed analysis of the key industry players has been done to provide insights into their business overview, services, key strategies, contracts, partnerships, agreements, new service launches, mergers and acquisitions, and recent developments associated with the plant biotechnology market. Competitive analysis of upcoming startups in the plant biotechnology market ecosystem is covered in this report. Furthermore, industry-specific trends such as technology analysis, ecosystem and market mapping, patent, regulatory landscape, among others, are also covered in the study.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall plant biotechnology and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
Analysis of key drivers (rise in seed replacement rate, High adoption of biotech crops, Growing demand for high-value crops, Use of plant growth regulators to combat climatic changes), restraints (Long approval period for new products, High R&D expenses on quality GM seed development), opportunities (Public-private partnerships in varietal development, Increasing use of molecular breeding technology, Increased production and yield of crops) and challenges (Unorganized new entrants with low profit to cost ratio, Lack of availability and access to high-quality plant biotechnology products) influencing the growth of the plant biotechnology market.
New product launch/Innovation: Detailed insights on research & development activities and new product launches in the plant biotechnology market.
Market Development: Comprehensive information about lucrative markets - the report analyzes the plant biotechnology market across varied regions.
Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the plant biotechnology market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product foot prints of leading players such as BASF SE (Germany), Bayer AG (Germany), Corteva Agroscience (US), Syngenta AG ( Switzerland), FMC Corporation (US), UPL (India), and other players in the plant biotechnology market.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 UNIT CONSIDERED
1.4.1 CURRENCY CONSIDERED
1.4.2 VOLUME UNIT CONSIDERED
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.2.2.1 Approach to estimate market size using top-down analysis
2.3 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PLANT BIOTECHNOLOGY MARKET
4.2 ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT TYPE AND KEY COUNTRY
4.3 PLANT BIOTECHNOLOGY MARKET: REGIONAL SNAPSHOT
4.4 PLANT BIOTECHNOLOGY MARKET, BY PRODUCT TYPE AND REGION
4.5 PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY AND REGION
4.6 PLANT BIOTECHNOLOGY MARKET, BY CROP TYPE AND REGION
4.7 PLANT BIOTECHNOLOGY MARKET, BY END USER AND REGION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GROWING USE OF COMMERCIAL SEEDS
5.2.3 DAMAGE AND LOSS OF AGRICULTURAL LAND
5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Rise in seed replacement rate
5.3.1.2 High adoption of biotech crops
5.3.1.3 Growing demand for high-value crops
5.3.1.4 Use of plant biotechnology to combat climatic changes
5.3.2 RESTRAINTS
5.3.2.1 Long approval period for new products
5.3.2.2 High R&D expenses on quality biotech seed development
5.3.3 OPPORTUNITIES
5.3.3.1 Public-private partnerships in varietal seed development
5.3.3.2 Increasing use of molecular breeding technology
5.3.3.3 Increased production and yield of crops
5.3.4 CHALLENGES
5.3.4.1 Unorganized new entrants with low profit-to-cost ratio
5.3.4.2 Lack of availability and access to high-quality plant biotechnology products
5.4 IMPACT OF AI/GEN AI ON PLANT BIOTECHNOLOGY MARKET